tiprankstipranks
Apellis Pharmaceuticals Inc (APLS)
NASDAQ:APLS
Holding APLS?
Track your performance easily

Apellis Pharmaceuticals (APLS) Income Statement

861 Followers

Apellis Pharmaceuticals Income Statement

Last quarter (Q3 2024), Apellis Pharmaceuticals's total revenue was $196.83M, an increase of 78.29% from the same quarter last year. In Q3, Apellis Pharmaceuticals's net income was $-57.45M. See Apellis Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 715.22M$ 396.59M$ 75.42M$ 66.56M$ 250.65M-
Cost of Revenue
$ 35.62M$ 58.51M$ 5.64M$ 5.20M$ 25.05M-
Gross Profit
$ 687.50M$ 338.08M$ 69.79M$ 61.36M$ 225.60M-
Operating Expense
$ 938.55M$ 855.20M$ 664.40M$ 602.84M$ 464.37M$ 288.01M
Operating Income
$ -223.33M$ -517.12M$ -594.61M$ -536.28M$ -213.73M$ -288.01M
Net Non Operating Interest Income Expense
$ 1.79M$ 8.65M$ 23.71M---
Other Income Expense
$ -13.74M$ -727.00K$ -33.18M$ 95.89M$ 99.37M$ 11.41M
Pretax Income
$ -247.80M$ -526.50M$ -651.50M$ -746.00M$ -343.03M$ -304.71M
Tax Provision
$ 2.30M$ 2.13M$ 669.00K$ 352.00K$ 1.84M$ -16.42M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -250.10M$ -528.63M$ -652.17M$ -746.35M$ -344.87M$ -299.42M
Basic EPS
$ -2.00$ -4.45$ -6.15$ -8.84$ -4.59$ -4.90
Diluted EPS
$ -2.00$ -4.45$ -6.15$ -8.84$ -4.59$ -4.90
Basic Average Shares
$ 722.62M$ 118.68M$ 106.11M$ 84.42M$ 75.16M$ 62.23M
Diluted Average Shares
$ 722.62M$ 118.68M$ 106.11M-$ 75.16M$ 62.23M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 952.85M$ 913.71M$ 670.03M$ 602.84M$ 464.37M$ 288.01M
Net Income From Continuing And Discontinued Operation
$ -250.10M$ -528.63M$ -652.17M$ -746.35M$ -344.87M$ -304.71M
Normalized Income
$ -159.04M-----
Interest Expense
------
EBIT
$ -213.22M$ -496.92M$ -618.88M$ -732.76M$ -313.09M$ -304.71M
EBITDA
$ -210.41M$ -495.21M$ -617.39M$ -731.27M$ -312.23M$ -302.13M
Currency in USD

Apellis Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis